NCT02182765View on ClinicalTrials.gov

Investigation of the Potential Pharmacokinetic Interaction Between Nevirapine, Abacavir and Amprenavir in HIV-1 Infected Non-Nucleoside Reverse Transcriptase Inhibitor (NNRTI) Naive Adults

PHASE1TerminatedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

April 30, 1999

Primary Completion Date

July 31, 2001

Conditions
HIV Infections
Interventions
DRUG

Nevirapine

DRUG

Amprenavir

DRUG

Abacavir

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY